Wound healing is accelerated by agonists of adenosine A2 (G(αs)- linked) receptors

Journal of Experimental Medicine

Volumn 186, Issue 9, 1997, Pages 1615-1620

  Montesinos, M Carmen ^a   Gadangi, Pratap ^a   Longaker, Michael ^a   Sung, Joanne ^a   Levine, Jamie ^a   Nilsen, Diana ^a   Reibman, Joan ^a   Li, Min ^a   Jiang, Chuan Kui ^a   Hirschhorn, Rochelle ^a   Recht, Phoebe A ^a   Ostad, Edward ^a   Levin, Richard I ^a   Cronstein, Bruce N ^a,b  

^a NEW YORK UNIVERSITY   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 8 (3 CHLOROSTYRYL)CAFFEINE; ADENOSINE A2 RECEPTOR AGONIST; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE RECEPTOR; MESSENGER RNA; RECEPTOR SUBTYPE; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TOPICAL DRUG ADMINISTRATION; WOUND CLOSURE; WOUND HEALING;

ADENOSINE; ADMINISTRATION, TOPICAL; ANIMALS; CELL LINE; DIABETES MELLITUS, EXPERIMENTAL; ENDOTHELIUM, VASCULAR; FEMALE; FIBROBLASTS; HUMANS; MALE; MICE; MICE, INBRED BALB C; PHENETHYLAMINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A; RECEPTORS, PURINERGIC P1; SKIN; UMBILICAL VEINS; WOUND HEALING;

EID: 0030698058     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.186.9.1615     Document Type: Article

References (24)

1. Pierce, G.F., T.A. Mustoe. 1995. Pharmacologic enhancement of wound healing. Ann. Rev. Med. 46:467-481.
2. Cronstein, B.N. 1994. Adenosine, an endogenous anti-inflammatory agent. J. Appl. Physiol. 76:5-13.
3. Ethier, M.F., V. Chander, and J.G. Dobson, Jr. 1993. Adenosine stimulates proliferation of human endothelial cells in culture. Am. J. Physiol. 265:H131-H138.
4. 2-adenosine and beta 2-adrenoceptors. Br. J. Pharmacol. 114:1577-1586.
5. Bull, D.A., E.A. Seftor, M.J. Hendrix, D.F. Larson, G.C. Hunter, and C.W. Putnam. 1993. Putative vascular endothelial cell chemotactic factors: comparison in a standardized migration assay. J. Surg. Res. 55:473-479.
6. Meininger, C.J., M.E. Schelling, and H.J. Granger. 1988. Adenosine and hypoxia stimulate proliferation and migration of endothelial cells. Am. J. Physiol. 255:H554-H562.
7. Cook, P.W., N.M. Ashton, and M.R. Pittelkow. 1995. Adenosine and adeinine nucleotides inhibit the autonomous and epidermal growth factor-mediated proliferation of cultured human keratinocytes. J. Invest. Dermatol. 104:976-981.
8. Ahmed, A.H., K. A. Jacobson, J. Kim, and L.A. Heppel. 1995. Presence of both A1 and A2a adenosine receptors in human cells and their interaction. Biochim. Biophys. Res. Commun. 208:871-878.
9. Olah, M.E., and G.L. Stiles. 1995. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu. Rev. Pharmacol. Toxicol. 35:581-606.
10. van Calker, D., M. Muller, and B. Hamprecht. 1979. Adenosine regulates, via two different types of receptors, the accumulation of cyclic AMP in cultured brain cells. J. Neurochem. 33:999-1005.
11. Londos, C., D.M.F. Cooper, and J. Wolff. 1980. Subclasses of external adenosine receptors. Proc. Natl. Acad. Sci. USA. 77:2551-2554.
12. Jaffe, E.A., R.L. Nachman, C.G. Becker, and C.R. Minick. 1973. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J. Clin. Invest. 52:2745-2756.
13. Levin, R.I., D.A. Moscatelli, and P.A. Recht. 1993. Oxalate, a potential atherogenic toxin of uremia, inhibits endothelial proliferation induced by heparin-bmding growth factors in vitro. Endothelium: Journal Endothelial Research 1:179-192.
14. Boyle, D.L., F.G. Sajjadi, and G.S. Firestein. 1996. Inhibition of synoviocyte collagenase gene expression by adenosine receptor stimulation. Arthritis Rheum. 39:923-930.
15. Covington, D.S., H. Xue, R. Pizzini, K.P. Lally, and R.J. Andrassy. 1993. Streptozotocin and alloxan are comparable agents in the diabetic model of impaired wound healing. Diabetes Res. 23:47-53.
16. Greenwald, D.P., S. Shumway, L.S. Zachary, M. LaBarbera, P. Albear, M. Temaner, and L.J. Gottlieb. 1993. Endogenous versus toxin-induced diabetes in rats: a mechanical comparison of two skin wound-healing models. Plast. Reconstr. Surg. 91:1087-1093.
17. Tsuboi, R., and D.B. Rifkin. 1990. Recombinant basic fibroblast growth factor stimulates wound healing in healing-impaired db/db mice. J. Exp. Med. 172:245-251.
18. 2 receptor occupancy regulates stimulated neutrophil function via activation of a serine/threonine protein phosphatase. J. Biol. Chem. 271: 17114-17118.
19. 2A-adenosine receptor in primary human endothelial cells. J. Biol. Chem. 272:5792-5799.
20. Parmely, M.J., W.-W. Zhou, C.K. Edwards III, D.R. Borcherding, R. Silverstein, and D.A. Morrison. 1993. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-α production and protect mice against endotoxin challenge. J. Immunol. 151:389-396.
21. Bouma, M.G., R.K. Stad, F.A.J.M. van den Wildenberg, and W.A. Buurman. 1994. Differential regulatory effects of adenosine on cytokine release by activated human monocytes. J. Immunol. 153:4159-4168.
22. Cronstein, B.N., D. Naime, and G.S. Firestein. 1995. The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine. Arthritis Rheum. 38:1040-1045.
23. 2 adenosine receptors. J. Immunol. 156: 3435-3442.
24. Bouma, M.G., F.A.J.M. van den Wildenberg, and W.A. Buurman. 1996. Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells. Am. J. Physiol. 39:C522-C529.